Zabofloxacin hydrochloride (DW-224a) is a potent and seletive inhibitor of the bacterial type II and IV topoisomerases . Zabofloxacin hydrochloride has excellent activity against gram-positive pathogens including Steptococcus aureus , Streptococcus pyogenes and S.pneumonia . Zabofloxacin hydrochloride is a novel fluoronaphthyridone quinolone that is considered as an alternative antibiotic for treatment of quinolone-susceptible (QSSP) and quinolone-resistant gonorrhea (QRSP)
In Vitro
Zabofloxacin shows a highly potent in vitro activity against clinical isolates of penicillin-sensitive S. pneumoniae (minimum inhibitory concentration, MIC 90 : 0.03 mg/L) and penicillin-resistant S. pneumoniae (MIC 90 : 0.03 mg/L). Against quinolone-resistant S. pneumoniae , zabofloxacin (MIC 90 : 1 mg/L) is more active than ciprofloxacin, sparfloxacin, and moxifloxacin. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:Topoisomerase I Topoisomerase II Quinolone
规格
别名
盐酸扎博沙星
规格或纯度
≥98%
英文名称
Zabofloxacin hydrochloride
生化机理
盐酸扎博沙星(DW-224a)是细菌 II 型和 IV 型拓扑异构酶的强效精选抑制剂。盐酸扎博沙星对革兰氏阳性病原体(包括金黄色葡萄球菌、化脓性链球菌、嗜酸性粒细胞)具有卓越的活性。